JP-listed companies
Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd.JP:4570

Market cap

¥4.3B

P/E ratio

22.9x

Income statement Balance sheet Cash flow

	Mar 31, 2012	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024
Cash and deposits	-	837	1,195	1,284	974	2,574	2,510	1,544	1,034	604	508	614	734
Notes receivable - trade	-	28	-	-	-	-	-	-	-	-	32	38	8
Accounts receivable - trade	-	165	-	-	-	-	-	-	-	-	142	185	183
Merchandise and finished goods	-	54	73	55	47	43	49	92	57	40	47	43	45
Work in process	-	126	125	123	128	121	123	127	134	133	133	136	143
Raw materials and supplies	-	65	83	90	99	108	106	119	154	138	146	139	133
Other	-	5	32	26	16	89	7	21	43	11	121	17	16
Short-term loans receivable	-	-	-	-	-	-	-	-	-	-	-	30	30
Current assets	-	1,279	1,688	1,826	1,485	3,129	2,998	2,112	1,593	1,125	1,130	1,165	1,262
Current portion of long-term loans receivable from subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	175	175
Other	-	5	32	26	16	89	7	21	43	11	121	17	16
Allowance for doubtful accounts	-	-	-	-	-	-	-	-	-	-	-	-7	-162
Current assets	-	1,279	1,688	1,826	1,485	3,129	2,998	2,112	1,593	1,125	1,130	1,165	1,262
Buildings	-	516	-	-	-	-	-	-	-	-	-	-	3
Buildings and structures	-	-	1,239	1,240	1,240	810	810	810	773	773	773	773	776
Accumulated depreciation	-	-	-732	-765	-795	-810	-810	-810	-773	-773	-773	-773	-773
Buildings and structures, net	-	-	507	475	445	-	-	-	-	-	-	-	3
Machinery and equipment	-	6	-	-	-	-	-	-	-	-	-	-	3
Machinery, equipment and vehicles	-	-	118	118	118	127	79	74	74	74	74	70	74
Accumulated depreciation	-	-	-97	-101	-104	-127	-79	-74	-74	-74	-74	-70	-71
Machinery, equipment and vehicles, net	-	-	22	18	14	-	-	-	-	-	-	-	3
Tools, furniture and fixtures	-	68	-	-	-	-	-	-	-	-	-	-	11
Land	-	363	363	363	363	123	122	114	114	127	120	119	119
Land	-	363	363	363	363	123	122	114	114	127	120	119	119
Other	-	0	565	589	614	600	589	588	568	562	513	510	523
Accumulated depreciation	-	-	-474	-508	-543	-600	-589	-588	-568	-562	-513	-510	-512
Other	-	-	91	81	71	-	-	-	-	-	-	-	11
Property, plant and equipment	-	962	982	936	1,574	123	122	114	114	127	120	119	136
Intangible assets	-	41	220	192	178	-	-	-	-	-	-	-	2
Software	-	37	-	-	-	-	-	-	-	-	-	-	2
Intangible assets	-	41	220	192	178	-	-	-	-	-	-	-	2
Investment securities	-	288	213	121	55	108	105	687	596	514	400	95	95
Deferred tax assets	-	-	-	-	-	-	-	4	-	-	-	-	68
Shares of subsidiaries and associates	-	1	-	-	-	-	-	-	-	-	-	10	10
Other	-	1	45	63	65	66	67	72	71	72	56	55	55
Long-term loans receivable from subsidiaries and associates	-	3	-	-	-	-	-	-	-	-	-	100	100
Investments and other assets	-	333	258	184	120	174	175	763	666	586	455	150	218
Long-term prepaid expenses	-	4	-	-	-	-	-	-	-	-	-	1	1
Insurance funds	-	36	-	-	-	-	-	-	-	-	-	35	37
Deferred tax assets	-	-	-	-	-	-	-	4	-	-	-	-	68
Other	-	1	45	63	65	66	67	72	71	72	56	55	55
Allowance for doubtful accounts	-	-	-	-	-	-	-	-	-	-	-	-100	-100
Investments and other assets	-	333	258	184	120	174	175	763	666	586	455	150	218
Non-current assets	-	1,335	1,459	1,312	1,871	297	297	877	780	713	576	269	356
Assets	-	2,614	3,147	3,138	3,356	3,426	3,295	2,988	2,373	1,838	1,705	1,434	1,619
Notes and accounts payable - trade	-	-	17	5	7	1	8	5	5	7	4	6	4
Accounts payable - trade	-	9	-	-	-	-	-	-	-	-	-	6	4
Short-term borrowings	-	100	100	-	-	-	-	-	20	20	125	130	135
Current portion of long-term borrowings	-	49	47	102	80	146	146	109	66	11	4	6	16
Income taxes payable	-	13	7	8	10	12	15	17	20	21	24	26	6
Accounts payable - other	-	41	-	-	-	-	-	-	-	-	-	39	44
Provision for bonuses	-	13	12	13	14	14	14	18	19	17	17	25	31
Contract liabilities	-	-	-	-	-	-	-	-	-	-	0	2	2
Other	-	0	91	67	54	61	119	124	88	70	54	59	65
Income taxes payable	-	13	7	8	10	12	15	17	20	21	24	26	6
Current liabilities	-	242	274	233	165	234	302	550	398	145	228	252	258
Accrued consumption taxes	-	7	-	-	-	-	-	-	-	-	-	9	9
Deposits received	-	7	-	-	-	-	-	-	-	-	-	5	8
Provision for bonuses	-	13	12	13	14	14	14	18	19	17	17	25	31
Current liabilities	-	242	274	233	165	234	302	550	398	145	228	252	258
Long-term borrowings	-	124	77	283	203	329	183	86	20	59	105	99	85
Asset retirement obligations	-	-	-	-	-	-	-	-	-	-	-	-	3
Provision for retirement benefits	-	1	-	-	-	-	-	-	-	-	-	5	8
Retirement benefit liability	-	-	1	2	2	2	2	6	7	5	4	5	8
Provision for loss on business of subsidiaries and associates	-	-	-	-	-	-	-	-	-	-	-	9	14
Non-current liabilities	-	125	78	285	405	1,850	975	292	27	64	109	104	95
Non-current liabilities	-	125	78	285	405	1,850	975	292	27	64	109	104	95
Liabilities	-	367	352	518	570	2,084	1,277	843	425	209	337	356	353
Share capital	-	1,572	1,846	1,846	1,946	2,272	2,636	2,793	3,029	3,029	3,029	3,029	50
Legal capital surplus	-	492	-	-	-	-	-	-	-	-	-	2,061	1,040
Capital surplus	-	492	878	878	979	1,304	1,669	1,825	2,061	2,061	2,061	2,061	1,040
Capital surplus	-	492	878	878	979	1,304	1,669	1,825	2,061	2,061	2,061	2,061	1,040
Retained earnings brought forward	-	196	-	-	-	-	-	-	-	-	-	-4,000	187
Retained earnings	-	196	50	-111	-143	-2,237	-2,290	-2,474	-3,142	-3,461	-3,720	-4,010	177
Retained earnings	-	196	50	-111	-143	-2,237	-2,290	-2,474	-3,142	-3,461	-3,720	-4,010	177
Treasury shares	-	-0	-0	-2	-2	-2	-2	-2	-2	-2	-2	-2	-2
Shareholders' equity	-	2,259	2,775	2,612	2,781	1,337	2,013	2,141	1,946	1,627	1,368	1,079	1,265
Net assets	2,093	2,247	2,795	2,620	2,786	1,341	2,018	2,146	1,948	1,629	1,368	1,079	1,265
Liabilities and net assets	-	2,614	3,147	3,138	3,356	3,426	3,295	2,988	2,373	1,838	1,705	1,434	1,619